Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06091527 · ClinicalTrials.gov registry record · NA

Treating Major Depression With Yoga Mono-therapy

A NA study of Depression Mild and Depression Moderate, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT06091527 is a NA study of Depression Mild and Depression Moderate that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 180 participants, below the 415-participant average among 7 other Depression Mild trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06091527, a NA study of Depression Mild and Depression Moderate, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.

Interventions

  • BEHAVIORAL Education
  • BEHAVIORAL Yoga practice

Study Locations (1)

California

  • Zuckerberg San Francisco General Hospital - San Francisco

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2024-10-25
Est. Completion 2026-06
Phase NA

What the Registry Record Tells You About NCT06091527

The ClinicalTrials.gov registry entry for NCT06091527 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 415-participant average among 7 other Depression Mild trials with a reported enrollment target (57% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression Mild appearing as the primary indexed condition, and to 2 interventions - of which Education is the first listed.

NCT06091527 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06091527 about?

NCT06091527 is a clinical study titled "Treating Major Depression With Yoga Mono-therapy". The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco G...

What is the current status of trial NCT06091527?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2024-10-25. Estimated completion is 2026-06.

What conditions does trial NCT06091527 study?

This clinical trial studies the following conditions: Depression Mild, Depression Moderate.

What interventions are being tested in trial NCT06091527?

The interventions under investigation include: Education (BEHAVIORAL), Yoga practice (BEHAVIORAL).

Who is sponsoring clinical trial NCT06091527?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06091527 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression Mild

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.